Effective with date of service April 17, 2023, NC Medicaid covers bevacizumab-adcd injection, for intravenous use (Vegzelma)
Medicaid Bulletin
Articles published prior to January 2018 are available in the Medicaid Bulletin Archive.
Effective May 30, 2023, NC Medicaid covers aripiprazole extended-release injectable suspension, for intramuscular use (Abilify Asimtufii).
This bulletin provides details on coverage for COVID-19 Vaccines and COVID-19 Counseling after the ending of the Federal Public Health Emergency.
Effective July 1, 2023, NC Medicaid has increased the Medicaid rate for Maternal Bundled Payments for pregnancy care.
A draft application for § 1915 (c) NC Innovation Waiver is posted for a 30-day public comment period.
The North Carolina Department of Health and Human Services recently awarded Acentra Health the contract as the Comprehensive Independent Assessment Entity (CIAE) for NC Medicaid.
Beneficiaries who will be covered by the Tailored Plans will continue to receive care as they do today.
Effective Jan. 1, 2023, the location field must have a valid value of 1 or 2.
The report and instructions for completing the report are updated to capture additional information needed for Credit Balance Audits
Includes an overview of the newest Center for Medicare and Medicaid Innovation payment model for Medicare, NC Medicaid’s involvement and timelines.